Belmont, CA, United States of America

Paul Beroza

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovations of Paul Beroza

Introduction

Paul Beroza is a notable inventor based in Belmont, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various disorders. With a total of four patents to his name, Beroza's work has the potential to impact the treatment of serious health conditions.

Latest Patents

Beroza's latest patents include innovative inhibitors of polo-like kinase. These inventions provide compounds with a specific structure, which can be utilized in pharmaceutical compositions. The compounds are designed for the treatment and prevention of disorders such as Parkinson's disease. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Paul Beroza has worked with prominent companies in the pharmaceutical industry. Notable among these are Elan Pharmaceuticals, Inc. and Telik, Inc. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Beroza has collaborated with several professionals in his field, including Robert Galemmo and Dean R Artis. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Paul Beroza's contributions to pharmaceutical innovation are noteworthy. His patents reflect a dedication to addressing critical health issues, particularly in the realm of neurodegenerative diseases. Through his work, Beroza continues to make a significant impact in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…